↓ Skip to main content

Anti-protein immunoglobulin M responses to pneumococcus are not associated with aging

Overview of attention for article published in Pneumonia, June 2018
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age

Mentioned by

twitter
3 X users

Citations

dimensions_citation
2 Dimensions

Readers on

mendeley
10 Mendeley
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Anti-protein immunoglobulin M responses to pneumococcus are not associated with aging
Published in
Pneumonia, June 2018
DOI 10.1186/s41479-018-0048-3
Pubmed ID
Authors

Esther L. German, Bahij Al-Hakim, Elena Mitsi, Shaun H. Pennington, Jenna F. Gritzfeld, Angie D. Hyder-Wright, Antonia Banyard, Stephen B. Gordon, Andrea M. Collins, Daniela M. Ferreira

Abstract

The incidence of community-acquired pneumonia and lower respiratory tract infection rises considerably in later life. Immunoglobulin M (IgM) antibody levels to pneumococcal capsular polysaccharide are known to decrease with age; however, whether levels of IgM antibody to pneumococcal proteins are subject to the same decline has not yet been investigated. This study measured serum levels and binding capacity of IgM antibody specific to the pneumococcal surface protein A (PspA) and an unencapsulated pneumococcal strain in serum isolated from hospital patients aged < 60 and ≥ 60, with and without lower respiratory tract infection. A group of young healthy volunteers was used as a comparator to represent adults at very low risk of pneumococcal pneumonia. IgM serum antibody levels were measured by enzyme-linked immunosorbent assay (ELISA) and flow cytometry was performed to assess IgM binding capacity. Linear regression and one-way analysis of variance (ANOVA) tests were used to analyse the results. Levels and binding capacity of IgM antibody to PspA and the unencapsulated pneumococcal strain were unchanged with age. These findings suggest that protein-based pneumococcal vaccines may provide protective immunity in the elderly. The LRTI trial (LRTI and control groups) was approved by the National Health Service Research Ethics Committee in October 2013 (12/NW/0713). Recruitment opened in January 2013 and was completed in July 2013. Healthy volunteer samples were taken from the EHPC dose-ranging and reproducibility trial, approved by the same Research Ethics Committee in October 2011 (11/NW/0592). Recruitment for this study ran from October 2011 until December 2012. LRTI trial: (NCT01861184), EHPC dose-ranging and reproducibility trial: (ISRCTN85403723).

X Demographics

X Demographics

The data shown below were collected from the profiles of 3 X users who shared this research output. Click here to find out more about how the information was compiled.
Mendeley readers

Mendeley readers

The data shown below were compiled from readership statistics for 10 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Unknown 10 100%

Demographic breakdown

Readers by professional status Count As %
Student > Ph. D. Student 2 20%
Student > Postgraduate 2 20%
Student > Bachelor 1 10%
Unknown 5 50%
Readers by discipline Count As %
Medicine and Dentistry 2 20%
Computer Science 1 10%
Immunology and Microbiology 1 10%
Agricultural and Biological Sciences 1 10%
Unknown 5 50%
Attention Score in Context

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 June 2018.
All research outputs
#15,009,334
of 23,088,369 outputs
Outputs from Pneumonia
#78
of 112 outputs
Outputs of similar age
#198,657
of 329,782 outputs
Outputs of similar age from Pneumonia
#4
of 4 outputs
Altmetric has tracked 23,088,369 research outputs across all sources so far. This one is in the 32nd percentile – i.e., 32% of other outputs scored the same or lower than it.
So far Altmetric has tracked 112 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 13.3. This one is in the 26th percentile – i.e., 26% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 329,782 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 36th percentile – i.e., 36% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 4 others from the same source and published within six weeks on either side of this one.